 NEW YORK and SAN FRANCISCO, Oct. 12, 2021 GLOBE NEWSWIRE -- Mountain Crest Acquisition Corp. II NASDAQ: MCAD, Mountain Crest II, a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. Better Therapeutics, a prescription digital therapeutics PDT company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCADs registration statement on Form S-4 File No. 333-255493 relating to the previously announced merger of MCAD and Better Therapeutics has been declared effective by the U.S. Securities and Exchange Commission as of October 12, 2021. MCAD also announced that it will hold its special meeting of stockholders the Special Meeting on October 27, 2021 at 10:00 am Eastern Time to, among other things, allow its stockholders to vote to approve the proposed Business Combination with Better Therapeutics. The Special Meeting will be completely virtual and conducted via live webcast at the following address Stockholders will be able to attend the meeting by using the control number that is printed on their proxy card. 